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ttp://dx.doi.org/10.1016/j.ajpath.2014.06.017Emphysema is characterized by loss of lung elasticity and irreversible air space enlargement, usually in the
later decades of life. The molecular mechanisms of emphysema remain poorly deﬁned. We identiﬁed a role
for a novel cathepsin, cathepsin E, in promoting emphysema by inducing mitochondrial ﬁssion. Unlike
previously reported cysteine cathepsins, which have been implicated in cigarette smoke-induced lung
disease, cathepsin E is a nonlysosomal intracellular aspartic protease whose function has been described
only in antigen processing. We examined lung tissue sections of persons with chronic obstructive pul-
monary disease, a clinical entity that includes emphysematous change. Human chronic obstructive pul-
monary disease lungs had markedly increased cathepsin E protein in the lung epithelium. We generated
lung epithelial-targeted transgenic cathepsin E mice and found that they develop emphysema. Over-
expression of cathepsin E resulted in increased E3 ubiquitin ligase parkin, mitochondrial ﬁssion protein
dynamin-related protein 1, caspase activation/apoptosis, and ultimately loss of lung parenchyma
resembling emphysema. Inhibiting dynamin-related protein 1, using a small molecule inhibitor in vitro or
in vivo, inhibited cathepsin E-induced apoptosis and emphysema. To the best of our knowledge, our study
is the ﬁrst to identify links between cathepsin E, mitochondrial ﬁssion, and caspase activation/apoptosis
in the pathogenesis of pulmonary emphysema. Our data expand the current understanding of molecular
mechanisms of emphysema development and may provide new therapeutic targets. (Am J Pathol 2014,
184: 2730e2741; http://dx.doi.org/10.1016/j.ajpath.2014.06.017)Supported by Flight Attendant Medical Research Institute grant 82384
(P.J.L.), NIH National Heart, Lung, and Blood Institute grants R01
HL090660 and R01 HL071595 (P.J.L.), American Heart Association grant
09FTF2090019 (P.M.), Yale Claude D. Pepper Older Americans Inde-
pendence Center grant P30 AG021342 (P.M.), and NIH National Institute
on Aging grant R03 AG 042358-02 (P.M.).
Disclosures: None declared.Emphysema is a major subset of chronic obstructive pulmo-
nary disease (COPD) and is deﬁned anatomically as the
destruction of the distal lung parenchyma and enlargement of
the air spaces. Pulmonary emphysema is one of the main
causes of morbidity and death worldwide. The most studied
factor in developing COPD has long been recognized to be
cigarette smoking. However, only 10% to 20% of heavy
smokers develop clinically signiﬁcant COPD.1,2 Importantly,
recent studies indicate that complementary pathogenic mech-
anisms, such as proteolytic/antiproteolytic imbalance, oxida-
tive stress, apoptosis, or altered innate immunity, are involved
in the development and progression of alveolar destruction.3e6
Cathepsins have been implicated in mediating alveolar
destruction via their proteolytic activity. Cathepsins are
intracellular hydrolases and include serine proteases (ca-
thepsins A and G), aspartic proteases (cathepsins D and E),
and cysteine cathepsins (cathepsins B, C, F, H, K, L, O, S, V,
X, and W). Cathepsin E (Cat E), a nonlysosomal intracellularstigative Pathology.
.aspartic protease, is homologous to aspartic protease
cathepsin D, a major proteolytic activity in the lysosomal
component.7 Recent studies have reported that Cat E plays an
important role in antigen processing via the major histo-
compatibility complex class II pathway, host defense against
cancer cells and invading microorganisms, gastric differen-
tiation, and development of signet-ring cell carcinoma.8e12
However, Cat E has not been linked to lung disease.
Human lung sections from persons with COPD indicated
increased expression of Cat E protein in the lung epithelial
cells. To investigate if increased expression of lung epithelial
Cathepsin E Promotes Pulmonary EmphysemaCat E could lead to emphysema, we generated lung-targeted
constitutive and inducible Cat E transgenic (Tg) mice. Our
data indicated that inducible Cat E Tg mice developed
emphysema-like lung changes as early as 1 week. We noted
robust caspase 3 activation, and, when mice were adminis-
tered a caspase inhibitor, emphysema was prevented. To our
surprise, we did not ﬁnd changes in caspases usually asso-
ciated with caspase 3 activation, such as caspases 8 and 9, in
Cat E Tg mice. Instead, we found signiﬁcant induction of a
mitochondrial ﬁssion protein, dynamin-related protein 1
(Drp1). When we inhibited Drp1 in Cat E Tg mice with
Mdivi-1, a small molecule Drp1 inhibitor, we completely
abolished the development of emphysema. Collectively, our
data indicate that increased Cat E is a clinically relevant
ﬁnding in human COPD and invoke a novel role for Cat E in
mitochondrial ﬁssion-induced emphysema.Materials and Methods
Animals
The CC10-Cat E constitutive Tg mice were generated by
cloning the human Cat E cDNA (Open Biosystems,
Lafayette, CO) downstream of the rat Clara cell 10-kDa
protein (CC10) promoter and upstream of human growth
hormone (hGH) polyadenylation and intronic sequence.
Two copies of the chicken b-globin insulator sequence were
ﬂanked on both ends of the transgene cassette (Figure 1A).
Tg mice were generated in (C57BL/6  SJL/J) F2 eggs by
using standard pronuclear injection and backcrossed onto
the C57BL/6 background for >10 generations before use.
The transgene was genotyped via PCR with the following
transgene-speciﬁc primers: 50-ACACGCATACCCACA-
CATAC-30 and 50-TACTGGAGTCACTCCTCCCA-30.
For generating inducible Cat E Tg mice, constructs that
contained the CC10 promoter, the reverse tetracycline
transactivator, hGH intronic and polyadenylation sequences
and a polymeric tetracycline operator; a minimal cytomeg-
alovirus promoter, human Cat E cDNA, and hGH were used
(Figure 1B). Tg mice were generated in (C57BL/6  SJL/J)Figure 1 Generation of lung epithelial-targeted constitutive Cat E Tg
mice. A: Construct for generation of lung epithelial-targeted, constitutive
CC10-Cat E Tg mice. B: Construct for generation of inducible CC10-Cat E Tg
mouse. CMV, cytomegalovirus; hCat E, human Cat E; INS, insulator; rtTA,
reverse tetracycline transactivator; Tet O, tetracycline operator.
The American Journal of Pathology - ajp.amjpathol.orgF2 eggs by using standard pronuclear injection and back-
crossed onto the C57BL/6 background for >10 generations
before use. All mice were evaluated for the presence of both
reverse tetracycline transactivator and Cat E with the use of
PCR analysis. PCR for Cat E used the following primers:
sense 50-TCCCCTCTGTGTACTGCACT-30 and antisense
50-TACTGGAGTCACTCCTCCCA-30.
In experiments performed with inducible Cat E Tg mice
and their littermate wild-type (WT) controls, all mice were
maintained on normal water until they were 1 month old.
They were then randomly assigned to receive either normal
water or water with doxycycline (dox) for the duration of
the experiment. Dox was administered at 500 mg/L in 4%
sucrose and kept in dark bottles to prevent light-induced
degradation. Mice were maintained under speciﬁc pathogen-
free conditions at the animal facility of Yale University
School of Medicine. Animal protocols were reviewed and
approved by the Animal Care and Use Committee at Yale
University.Administration of Mdivi-1 and Z-VAD
Small molecule Drp1 inhibitor, Mdivi-1 (50 mg/kg body
weight/day; Enzo Life Sciences, Farmingdale, NY) and
broad caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-
ﬂuoromethyl ketone (Z-VAD; 3 mg/kg body weight/day;
Calbiochem, La Jolla, CA) were administered to Cat E Tg
mice and WT littermates by intraperitoneal injection.
Mdivi-1 or Z-VAD was given 1 day before dox water and
was repeated daily for 2 weeks.Exposure to Cigarette Smoke
Eight-week-old C57BL/6J mice were exposed to room air or
the smoke from nonﬁltered research cigarettes (2R4; Uni-
versity of Kentucky, Lexington, KY) as previously
described.13 During the ﬁrst week, mice received half a
cigarette twice a day to allow for acclimation, and then two
cigarettes per day (one cigarette per session, two sessions
per day) for up to 6 months.Bronchoalveolar Lavage and Lung Inﬂammation
Lung inﬂammation was assessed by bronchoalveolar lavage,
as described previously.14 In brief, animals were anes-
thetized, a median sternotomy was performed, the trachea
was dissected free from the underlying soft tissues, and
bronchoalveolar lavage was performed by perfusing the
lungs in situ with 0.9 mL of phosphate-buffered saline and
gently aspirating the ﬂuid back. This procedure was
repeated twice. Samples were then pooled and centrifuged,
and total cell numbers and differentials were assessed. The
cell-free bronchoalveolar lavage ﬂuid was stored at 70C
until used.2731
Zhang et alLung Volume, Histological Evaluation, and
Morphometric Analysis
Lung volume was assessed as previously described.6,15 In
brief, mice were anesthetized, the trachea was cannulated,
and the lungs were removed and inﬂated with phosphate-
buffered saline at 25 cm H2O. The size of the lung was
evaluated by volume displacement. Hematoxylin and eosin
staining was performed after pressure ﬁxation with 10%
buffered formalin solution in the Research Pathology
Laboratory at Yale University. Alveolar size was estimated
from the mean chord length of the air space as previously
described.6,15
Immunoﬂuorescence and Immunohistochemistry
Formalin-ﬁxed, parafﬁn-embedded lung tissue sections
from human (COPD and non-COPD) and mouse lungs were
analyzed for Cat E and surfactant protein C immunoﬂuo-
rescence and immunohistochemical staining as described
previously.16,17 Cat E (dilution 1:400) and surfactant protein
C (dilution 1:200) antibodies were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA).
Cell Culture
MLE12 cells, a murine lung epithelial cell line, were purchased
from ATCC (Manassas, VA) and cultured as previously
described.18 For Mdivi-1 treatment, MLE12 cells were treated
with Mdivi-1 (50 mmol/L) 30 minutes before treatment with
activated Cat E (100 ng/mL). Human Cat E-overexpressing
plasmid (pCC10-Cat E), empty vector, or Drp1K38A, a
dominant-negative mutant of Drp1, was transfected into
MLE12 cells as previously described19 by using Lipofactamine
2000 (Invitrogen, Carlsbad, CA). After incubation, cells were
cultured for an additional 48 hours in complete medium.
Measurement of Caspase 3, 8, and 9 Activities
Caspase 3, 8, and 9 activities were measured according to the
manufacturer’s instructions and as previously described.18
Apoptosis Assays
Terminal deoxynucleotidyltransferase-dUTP nick end-
labeling (TUNEL) and ﬂow cytometric assays were used
as previously described.20
Western Blot Analysis
Protein was extracted from cell or lung tissue lysates, electro-
transferred, and then immunoblotted with rabbit Cat E (Santa
Cruz Biotechnology), rabbit caspase 3 (Santa Cruz Biotech-
nology), or rabbit Drp1 (Abcam, Cambridge, MA) antibodies.
Detection was performed with Phototope-HRP Western Blot
Detection System (Cell Signaling Technology, Danvers, MA).2732Equivalent sample loading was conﬁrmed by stripping mem-
branes with Restore Western Blot Stripping Buffer (Thermo
Scientiﬁc, Rockford, IL) and reprobing with antieb-tubulin or
antieb-actin antibodies (Santa Cruz Biotechnology).
RNA Extraction and mRNA Analyses
Total RNA extraction and mRNA analyses (reverse
transcription-PCR or real-time RT-PCR) were described
previously.6,21 Primers used for mouse Cat E were sense,
50-TCCCAGACACCGCTCCTCCAG-30, and antisense,
50-GGATTTGGGGCTGCTGGTTTC-30; Parkin sense, 50-
TGGGAGGTGTGCTGTGCCCCCG-30, and antisense, 50-
AAAACAAACCCGCAGCCCAGGCCGT-30; Drp1 sense,
50-CAGGAATTGTTACGGTTCCCTAA-30, and antisense,
50-CCTGAATTAACTTGTCCCGTGA-30; ﬁssion protein 1
(Fis1) sense, 50-AGAGCACGCAATTTGAATATGCC-30,
and antisense, 50-ATAGTCCCGCTGTTCCTCTTT-30;
mitofusin 1 (Mfn1) sense, 50-AACTTGATCGAATAGC-
ATCCGAG-30, and antisense, 50-GCATTGCATTGATGA-
CAGAGC-30; mitofusin 2 (Mfn2) sense, 50-CTGGGGACCG-
GATCTTCTTC-30, and antisense, 50-CTGCCTCTCGAAA-
TTCTGAAACT-30; optic atrophy 1 (Opa1) sense, 50-CGAC-
TTTGCCGAGGATAGCTT-30, and antisense, 50-CGTT-
GTGAACACACTGCTCTTG-30; and for mouse glyceralde-
hyde-3-phosphate dehydrogenase, sense, 50-TGTGTCCG-
TCGTGGATCTGA-30, and antisense, 50-CCTGCTTCAC-
CACCTTCTTGAT-30.
Measurement of Cat E Enzymatic Activity
Enzymatic activity of lung tissue Cat E was measured as
described,22with somemodiﬁcations.Brieﬂy, a total volumeof
100 mL of reaction mixture that contained 80 mL of buffer
(50 mmol/L of sodium acetate buffer, pH 4.0), 10 mL of 200
mmol/L substrate solution, and 10 mL of sample solution was
incubated at 40C for 10 minutes, and the reaction was termi-
nated by adding 2 mL of 5% trichloroacetic acid. The increase
inﬂuorescence intensity producedby substrate cleavageduring
incubationwasmeasured at an emissionwavelength of 393 nm
with excitation at 328 nm by using a ﬂuorescence spectro-
photometer. The recombinant Cat E standard was purchased
from R&D Systems (Minneapolis, MN). The Cat E hydrolysis
ﬂuorogenic substrateMOCAc-Gly-Ser-Pro-Ala-Phe-Leu-Ala-
Lys (Dnp)-D-Arg-NH2 (KYS-1) was purchased from Peptide
International Inc. (Louisville, KY).
Preparation of siRNA and Transfection of siRNA
Duplexes
Mouse Cat E siRNA targeting sequence NNCGAGUCCU-
GUAAUGUGUAU was synthesized in 20-deprotected,
duplexed, desalted, and puriﬁed form by Dharmacon Research
Inc. (Lafayette, CO). The sense and antisense strands of mouse
Cat E siRNA were sense, 50-CGAGUCCUGUAAUGU-
GUAUdTdT-30, and antisense, 50-AUACACAUUACAGGA-ajp.amjpathol.org - The American Journal of Pathology
Figure 2 Human COPD lung section and smoking mouse lungs showed
increased Cat E expression. Representative immunohistochemical staining
for Cat E in human lung tissue with (B) or without (A) COPD. Cat E protein is
detected as red cytoplasmic staining (single arrow, airway epithelium;
double arrow, lung alveolar epithelial cells). C: Cat E expression in human
COPD lung alveolar epithelial cells [Cat E (red); SP-C (green); arrows,
alveolar epithelial cells with Cat E expression]. D: Cat E expression is
increased in mouse lungs after 6 months of CS compared with NS lungs.
Data are expressed as means  SEM. *P < 0.05 versus mouse NS lungs.
Original magniﬁcation: 200 (A and B); 400 (C). CS, cigarette smoke;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; NS, without smoking;
SP-C, surfactant protein C.
Cathepsin E Promotes Pulmonary EmphysemaCUCGdTdT-30. Parkin siRNA was purchased from Santa
Cruz Biotechnology Inc. Nonspeciﬁc siRNA scrambled
duplex probes (sense, 50-GCGCGCUUUGUAGGAUUCG-30;
antisense, 50-CGAAUCCUACAAAGCGCGC-30) were syn-
thesized by Dharmacon Research Inc. as previously
described.6,20 Transfection of siRNA duplexes was described
previously.6,19,20
Measurement of Proteasome 20S Activity
The proteasome 20S activity was evaluated in whole-cell
lysate by means of a proteasome 20S activity kit (APT 280;
Millipore, Billerica, MA), as described by the manufacturer.
Whole-cell lysate protein extract (10 mg) was incubated in
the provided buffer with 3.8 mg of ﬂuorophore-linked
peptide substrate (LLVY-7-amino-4-methylcoumarin) for
120 minutes at 37C. Proteasome activity was measured by
quantiﬁcation of relative ﬂuorescent units from the release
of the ﬂuorescent-cleaved product LLVY-7-amino-4-
methylcoumarin by using a 380/460-nm ﬁlter. A solution
of the proteasome 20S subunit and the proteasome inhibitor
lactacystin were used as controls for the assay.
Assessment of Mitochondrial Morphology
Cultured MLE12 cells were treated with or without activated
Cat E (100 ng/mL) for 16 hours, and then the cells were
processed for mitochondrial immunoﬂuorescence or trans-
mission electron microscopy studies. For mitochondrial
immunoﬂuorescence studies, the cells were stained with
1:2000 diluted MitoTracker Red CMX Ros Mitochondrial
Probe (Invitrogen) at 37C for 15 minutes. After washing, the
cells were ﬁxed with 3.7% formaldehyde and counterstained
with DAPI mounting solution. For transmission electron
microscopy studies, the cells were ﬁxed with 2% (v/v) para-
formaldehyde, 2.5% (v/v) glutaraldehyde in 0.1 mol/L so-
dium cacodylate, postﬁxed with 1% (w/v) osmium tetroxide,
followed by 1% (w/v) uranyl acetate, dehydrated, and
embedded in LX112 resin. Ultrathin sections stained with
uranyl acetate followed by lead citrate were viewed on a FEI
Tecnai transmission electron microscope (Hillsboro, OR).
Statistical Analysis
Data are expressed as means  SEM and were analyzed by
two-tailed Student’s t-test. P < 0.05 was considered to be
signiﬁcant.
Results
Increased Cat E in Human COPD and Smoking Mouse
Lungs
To determine the clinical relevance of Cat E in COPD, we
performed immunohistochemistry for Cat E on 10 lung
sections obtained from former smokers with COPD (asThe American Journal of Pathology - ajp.amjpathol.orgdeﬁned by criteria of the global initiative for COPD) and on
6 lung sections obtained from nonsmokers without COPD,
provided by the Lung Pathology Department of Yale Uni-
versity School of Medicine. COPD lung sections had
signiﬁcantly increased Cat E staining compared with lung
sections without COPD (Figure 2, AeC). COPD lungs had
increased lung epithelial Cat E staining compared with the
weak and scattered staining in non-COPD lungs. Given that
smoking can cause COPD, smoke-exposed mice were used
to study the pathogenesis of COPD. We investigated
whether smoking can induce Cat E expression in mouse
lungs. Mouse lungs showed a signiﬁcant Cat E mRNA
expression after 6 months of smoking, a time point
commonly associated with COPD-like changes in mouse
lungs (Figure 2D).
Cat E Overexpression Results in Emphysema
To determine whether increased Cat E in the lung causes
emphysema, we generated lung epithelial-speciﬁc, Tg Cat E
overexpression mice. We ﬁrst generated constitutively
expressed lung epithelial-speciﬁc Tg mice to determine
whether any effect was on lung architecture by Cat E in-
duction. We ﬁrst conﬁrmed increased Cat E protein
expression in lungs by using immunohistochemistry
(Figure 3A) and Western blot analysis (Figure 3B). We also
observed increased Cat E enzymatic activity in Cat E Tg
lung tissues (Figure 3C). By 1 month, constitutive Cat E Tg
mice showed histological lung changes consistent with2733
Figure 3 Lung epithelial-targeted constitutive Cat E Tg mice develop emphysema. A: Cat E protein expression in cCat E Tgþ mouse lungs and Tg WT
littermates detected by immunohistochemistry (arrow, positive brown staining). B: Cat E protein expression in cCat E Tgþ mouse lungs compared with Tg
mouse lungs detected by Western blot analysis. C: cCat E Tgþ mouse lungs showed increased Cat E enzymatic activity compared with Tg WT littermates. D:
Representative lung histology of 3-month-old cCat E Tgþ mouse lungs with emphysema versus WT littermates. E: cCat E Tgþ and Tg mouse lung volumes at
different ages. F: cCat E Tgþ and Tg mouse lung mean linear chord lengths at different ages. Data are expressed as means  SEM. *P < 0.05 versus cCat E Tg
WT littermates. Original magniﬁcation: 400 (A); 100 (D). cCat E, constitutive CC10-Cat E.
Zhang et alemphysema, as characterized by enlargement of the air
spaces distal to the terminal bronchioles and loss of the
normal alveolar architecture (Figure 3D). These changes
were accompanied by increased lung volumes (Figure 3E)
and mean linear chord lengths (Figure 3F).
We then generated dox-inducible Cat E Tg mice to
regulate Cat E postnatally. Inducible Cat E Tg mice and WT
littermates were randomly assigned to receive normal waterFigure 4 Lung epithelial-targeted inducible Cat E Tg mice develop emphysema
water) and Tg WT littermates detected by immunoﬂuorescence (arrow, positive
weeks of dox water compared with Tg mouse lungs detected by Western blot ana
compared with Cat E Tg WT littermates. D: Representative lung histology of iCat
littermates. E: iCat E Tgþ and Tg mouse lung volumes after a time course of d
different time points after a time course of dox water. Data are expressed as means
200 (A); 100 (D). iCat E, inducible CC10-Cat E.
2734or dox-containing water, starting at 1 month of age. Similar
to constitutive Tg mice, inducible Tg mice showed
increased Cat E protein expression by immunoﬂuorescence
staining (Figure 4A), Western blot analysis (Figure 4B), and
Cat E enzymatic activity (Figure 4C). Inducible Cat E Tg
mice also showed histological evidence of emphysema,
increased lung volumes, and increased mean linear chord
lengths (Figure 4, DeF). We used inducible Tg mice and. A: Cat E protein expression in iCat E Tgþ mouse lungs (after 2 weeks of dox
red staining). B: Cat E protein expression in iCat E Tgþ mouse lungs after 2
lysis. C: iCat E Tgþ mouse lungs showed increased Cat E enzymatic activity
E Tgþ mouse lungs (after 2 weeks of dox water) with emphysema versus WT
ox water. F: iCat E Tgþ and Tg mouse lung mean linear chord lengths at
 SEM. *P < 0.05 versus iCat E Tg WT littermates. Original magniﬁcation:
ajp.amjpathol.org - The American Journal of Pathology
Figure 5 Cat E causes caspase 3-mediated apoptosis, and caspase inhibition prevents the development of emphysema. A: Representative sections from iCat E Tgþ
mouse lung stained for TUNEL after 2 weeks of dox water showed increased TUNEL positivity compared with Tg littermate WT mouse lung (TUNEL staining; arrow,
nuclear blue staining). B: Quantitation of TUNEL-positive cells is expressed as percentage of total cells in lung sections. C: MLE12 cells were treated with 100 ng/mL
human recombinant active Cat E for 48 hours and apoptosis was analyzed by ﬂow cytometry. D: Representative caspase 3 activation detected by immunohistochemical
staining in iCat E Tgþ mouse lung compared with Tg littermate WT mouse lung (arrow, positive red cytoplasmic staining for active caspase 3). E: iCat E Tgþ mouse
lungs showed increased caspase 3 activity. F:MLE12 cells treated with recombinant active Cat E (100 ng/mL) for 48 hours showed increased caspase 3 activity. Z-VAD, a
broad caspase inhibitor, was administered 1 day before dox water and repeated daily for 2 weeks via intraperitoneal injection (3 mg/kg body weight/day). Z-VAD
treatment decreased lung caspase 3 activity in iCat E Tgþ mouse lungs (G), TUNEL-positive apoptotic cells in iCat E Tgþ mouse lungs (H), lung volume in iCat E Tgþ
mouse lungs (I), and lung emphysema in iCat E Tgþmice, as measured by mean linear chord length (J). Data are expressed asmeans SEM (B, C, and EeJ). *P< 0.05
versus MLE12 cells without active Cat E treatment CTRL (C and F), versus iCat E TgWT littermates (B and E), versus iCat E Tgþmice treated with Z-VAD or iCat E TgWT
littermates (GeJ). Original magniﬁcation: 400 (A); 600 (D). CTRL, control; iCat E, inducible CC10-Cat E; RFU, relative ﬂuorescence unit.
Cathepsin E Promotes Pulmonary EmphysemaWT littermates for the subsequent studies. Of note, neither
constitutive nor inducible Cat E Tg mouse lungs exhibited
inﬂammatory cell inﬂux (data not shown).
Inhibiting Apoptosis Prevents Cat E-Induced Emphysema
Our previous work and other studies have found that apoptosis
plays an important role in the pathogenesis of emphysema in
animal models and humans.4,6,23 Therefore, we evaluated
apoptosis in Cat E Tg mice by TUNEL staining and found an
increased number of TUNEL-positive cells in the lungs of Cat
E Tg mice compared with WT lungs (Figure 5, A and B). We
conﬁrmed our results by using ﬂow cytometric quantitation of
annexin Vepropidium iodide staining in MLE12 cells, which
exhibited signiﬁcantly increased apoptosis after treatment with
recombinant, activated Cat E compared with control cells
without Cat E treatment (Figure 5C). Next, we asked whether
caspase 3-mediated cell death existed in Cat E Tgmouse lungs
and found a signiﬁcant increase in activated caspase 3-positive
cells (Figure 5D) and caspase 3 activity (Figure 5E) in Cat E
Tg mouse lungs. Similarly, in MLE12 cells we also identiﬁed
increased caspase 3 activity and cleavage after treatment withThe American Journal of Pathology - ajp.amjpathol.orgrecombinant active Cat E compared with control cells
(Figure 5F). However, we did not ﬁnd differences in caspase 8
or caspase 9 activation in Cat E Tg mouse lungs or Cat
E-treated MLE12 cell. To determine whether increased cas-
pase 3 activity is a causative factor in developing emphysema,
we used a broad caspase inhibitor, Z-VAD. Cat E Tg mice
treatedwith Z-VAD showed a signiﬁcant decrease in caspase 3
activity and apoptosis (Figure 5, G and H). Z-VAD also pre-
vented emphysema, as shown by decreased lung volume
(Figure 5I) and mean linear chord length (Figure 5J). Our data
indicated that Cat E overexpression leads to increased caspase
3-mediated cell death and emphysema.
Cat E Overexpression Induces Mitochondrial Fission
Recent studies have found that proteins regulating mito-
chondrial ﬁssion and fusion dynamics are associated with a
broad range of cellular functions and disease-related pro-
cesses such as apoptosis, aging, chronic heart diseases,
diabetes, or neuron-degenerative diseases.24e30 However,
the association of mitochondrial dynamics and pulmonary
emphysema was not clear. We ﬁrst investigated if there2735
Figure 6 Cat E induces mitochondria ﬁssion
and mitochondrial ﬁssion protein Drp1. A: MLE12
cells were treated with 100 ng/mL human recom-
binant active Cat E for 16 hours, and mitochondrial
morphology was observed by transmission electron
microscope. Cells treated with Cat E showed
disorganized, smaller, and fragmented mitochon-
dria compared with control cells (arrow, mito-
chondrion undergoing ﬁssion). B: MLE12 cells were
treated with 100 ng/mL human recombinant active
Cat E for 16 hours, and mitochondria morphology
was observed by mitochondrial immunoﬂuores-
cence. Cells treated with active Cat E showed
disorganized, smaller, and fragmented mitochon-
dria (single arrow, fragmented mitochondria)
compared with control cells (double arrow, elon-
gated mitochondria). C: iCat E Tgþ mouse lungs
(after 2 weeks of dox water) showed increased
Drp1 ﬁssion protein and proapoptotic Bax
expression by Western blot analysis. D: iCat E Tgþ
mouse lungs showed increased Drp1 mRNA
expression detected by real-time reverse tran-
scription PCR. Data are expressed as means  SEM.
*P < 0.05 versus iCat E Tg WT littermates.
GAPDH, glyceraldehyde-3-phosphate dehydroge-
nase; iCat E, inducible CC10-Cat E.
Zhang et alwere changes in mitochondrial morphology to indicate
mitochondrial fusion or ﬁssion by using mitochondrial
immunoﬂuorescence and transmission electron microscopy
studies. Compared with control groups, Cat E-treated
MLE12 cells showed disorganized, smaller, and fragmented
mitochondria by mitochondrial immunoﬂuorescence and
transmission electron microscopy studies, indicating
increased mitochondrial ﬁssion (Figure 6, A and B). We
then studied if changes in proteins were associated with
mitochondrial ﬁssion and fusion and found ﬁssion protein
Drp1 was signiﬁcantly increased at protein and mRNA
levels in Cat E Tg mouse lungs compared with WT litter-
mates (Figure 6, C and D). No differences were found in
other ﬁssion proteins such as Fis1 and in fusion proteins
such as Opa1, Mfn1, and Mfn2 between lungs of Cat E Tg
and WT mice (data not shown).
Inhibition of Mitochondrial Fission Protein Drp1
Decreases Caspase 3 Activity and Prevents Emphysema
in Cat E Tg Mice
Mitochondrial ﬁssion and fusion have important roles in
regulating cell apoptosis.31 Drp1 has been reported to
colocalize with Bax in mitochondria during apoptosis. We
identiﬁed increased Drp1 expression and Bax expression in2736Cat E Tg mouse lungs (Figure 6C). Next, we investigated if
the increased mitochondrial ﬁssion mediator Drp1 is
involved in caspase 3 activation, apoptosis, and developing
emphysema in vitro or in vivo. Our data indicated that in-
hibition of Drp1 with the highly speciﬁc small molecule
Drp1 inhibitor, Mdivi-1,24,32 inhibited caspase 3 cleavage/
activation in MLE12 cells treated with recombinant active
Cat E (Figure 7A) and caspase 3 activity in Cat E Tg mouse
lungs (Figure 7B). We also found that inhibition of Drp1
with Drp1K38A,33,34 a dominant-negative mutant of Drp1,
decreased apoptosis in MLE12 cells transfected with Cat E
overexpressing plasmid (Figure 7C). Mdivi-1 administration
in vivo decreased apoptosis (Figure 7D) and ameliorated
emphysema in inducible Cat E Tg mice (Figure 7, EeG).
These data suggested that mitochondrial ﬁssion regulates
caspase 3-mediated apoptosis in the lung and that inhibition
of mitochondrial ﬁssion protein Drp1 will prevent apoptosis
and emphysema.
Parkin Is Involved in Cat E-Regulated Mitochondrial
Fission and Drp1 Expression
Parkin, an E3 ubiquitin ligase, plays a critical role in regulating
mitochondrial ﬁssion and fusion.35 Recent studies have sug-
gested that Parkin interacts with proteins that regulateajp.amjpathol.org - The American Journal of Pathology
Figure 7 Inhibiting Drp1 prevents Cat E-induced emphysema. A: MLE12 cells treated with 100 ng/mL human recombinant active Cat E showed increased
activation of caspase 3 by demonstrating caspase 3 cleavage detected by Western blot analysis (lanes 5 and 6). Mdivi-1 was administered 1 day before dox water
and repeated daily for 2 weeks via intraperitoneal injection (50 mg/kg body weight/day). B: Mdivi-1 treatment inhibits caspase 3 activity in iCat E Tgþ mouse
lungs. C: MLE12 cells were transfected with pCC10-Cat E, empty vector, or Drp1K38A, a dominant-negative mutant of Drp1. After incubation, cells were cultured
for an additional 48 hours, and apoptosis was analyzed by ﬂow cytometry. D: Mdivi-1 treatment signiﬁcantly decreases TUNEL-positive lung cells in iCat E Tgþ
mouse lungs. E: Mdivi-1 treatment decreases lung volumes in iCat E Tgþmice. F:Mdivi-1 treatment decreases lung emphysema in iCat E Tgþmice, as measured by
mean linear chord length. G: Representative lung histology of iCat E Tgþmouse lungs with (right panel) or without (middle panel) Mdivi-1 treatment versus WT
littermates (left panel). Data are expressed as means  SEM (BeF). *P < 0.05 versus Cat E Tgþ mice (B and DeF), **P < 0.01 versus MLE12 cells transfected
with pCC10-CatE (C). Original magniﬁcation, 100. CTRL, MLE12 cells without Cat E treatment control; DMSO, dimethyl sulfoxide, solvent for Mdivi-1; iCat E,
inducible CC10-Cat E; Mdivi-1, small molecule Drp1 inhibitor; Mdivi-1/Cat E, MLE12 cells treated with 50 mmol/L Mdivi-1 for 30 minutes followed by 100 ng/mL
human recombinant active Cat E treatment for 48 hours; pCC10-CatE, Cat E overexpressing plasmid; RFU, relative ﬂuorescence unit.
Cathepsin E Promotes Pulmonary Emphysemamitochondrial ﬁssion and fusion, such as Drp1 and Mfn1/2,
through pathways that depend on the ubiquitin-proteasome
system (UPS).35e38 The UPS pathway is the main proteolytic
system in the cytosol of eukaryotic cells. The critical protease in
this pathway is the 26S proteasome, an ATP-dependent pro-
teolytic complex, which is formed by 20S proteasome and two
19S regulatory complexes. The 20S proteasome, catalytic core
of the proteasome complex, is responsible for the breakdown of
key proteins involved with apoptosis, DNA repair, endocytosis,
and cell cycle control.39 We sought to investigate if Cat E
regulates Parkin and the UPS pathway. We identiﬁed increased
Parkin expression in both Cat E Tg mouse lungs (Figure 8A)
and MLE12 cells treated with recombinant active Cat E
(Figure 8B). The activation of the UPS pathway, as measured
by proteasome 20S activity, was also increased in MLE12 cells
treated with recombinant active Cat E (Figure 8E). To establish
the relationship between Cat E and Parkin, we silenced Cat E
expression by using Cat E siRNA in MLE12 cells and foundThe American Journal of Pathology - ajp.amjpathol.orgthat Cat E silencing decreased Parkin expression (Figure 8C).
Next, we silenced Parkin in MLE12 cells and found decreased
Cat E-induced Drp1 expression (Figure 8D) and proteasome
20S activity (Figure 8E). These data indicated that Cat E reg-
ulates Parkin and subsequent UPS activity and mitochondrial
ﬁssion protein Drp1.Discussion
Emphysema is characterized by loss of lung tissue and,
eventually, loss of lung function. Emphysema is a main
subset of COPD, a common cause of morbidity and mortality
for which speciﬁc therapies are limited. Although most
commonly associated with cigarette smoking, a less appre-
ciated fact is that emphysema occurs in most nonsmokers.
Inhaled irritants, such as cigarette smoke, accelerate
emphysema. COPD is predicted to become the third-leading2737
Figure 8 Parkin mediates Cat E-regulated mitochondrial ﬁssion and Drp1 induction. A: iCat E Tgþ mouse lungs (after 2 weeks of dox water) showed
increased Parkin expression by Western blot analysis. B: MLE12 cells treated with 100 ng/mL human recombinant active Cat E for 16 hours showed increased
Parkin expression by Western blot analysis. C: MLE12 cells transfected with 34 nmol/L NS siRNA or Cat E siRNA showed decreased Parkin expression as analyzed
by real-time reverse transcription PCR. D: MLE12 cells transfected with 34 nmol/L NS siRNA or Parkin siRNA showed decreased Drp1 expression as analyzed by
real-time reverse transcription PCR. MLE12 cells transfected with 34 nmol/L NS siRNA or Parkin siRNA showed decreased proteasome 20S activity. Data are
expressed as means  SEM. *P < 0.05 versus NS siRNA (C) or Cat E (D and E) group. CTRL, control; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; iCat E,
inducible CC10-Cat E; NS, nonspeciﬁc; RFU, relative ﬂuorescence unit.
Zhang et alcause of death in 2020 because of the aging of the world
population, increasing industrialization, and an expanding
epidemic of smoking.40e43 Epidemiological studies,
population-based cohort studies, lung cancer screening
studies, and interventional trials have also found a close
relationship between COPD and lung cancer, also becoming
more prevalent.40,44 Insights into the cellular and molecular
processes that govern lung tissue maintenance and destruc-
tion may yield effective therapies. To the best of our
knowledge, we are the ﬁrst to report that Cat E is increased in
human COPD lung tissues and, when overexpressed in lung
epithelial cells in vivo, is sufﬁcient to cause lung emphysema.
Rather than invoking Cat E’s putative protease function, we
found that Cat E-induced emphysema is due to increased
mitochondrial ﬁssion and apoptosis. These studies highlight
a novel role of Cat E and mitochondrial ﬁssion in the path-
ogenesis of COPD.
Cat E has been reported to be localized in different cellular
compartments, such as plasma membranes, endosomal
structures, the endoplasmic reticulum, and the Golgi appa-
ratus.9,12 In humans, Cat E can be found in dendritic cells,
epithelial cells, lymphocytes, osteoclasts, spleen, and lymph
nodes.9,45,46 To date, studies have found that Cat E plays an
important role in antigen processing via the major histo-
compatibility complex class II pathway in host defense
against cancer cells, microorganisms, gastric differentiation,
and development of signet-ring cell carcinoma.8e11 Antigen
processing and autoimmunity in the pathogenesis of emphy-
sema have been reported,47 which invokes an intriguing role
for Cat E in emphysema. COPD-inducing agents, such as2738cigarette smoke, may stimulate Cat E expression from
epithelial cells and initiate the cascade of molecular changes
that lead to COPD. Our lung epithelial-targeted Tg mice and
cell culture data suggest previously unidentiﬁed effects of Cat
E on mitochondrial dynamics and cell death.
Unlike other cathepsins, Cat E has not been reported to
exhibit proteolytic activity. In addition, endogenous sub-
strates for Cat E have not been fully identiﬁed. Therefore, we
explored non-protease mechanisms for the actions of Cat
E-induced emphysema. On the basis of previous work that
reported the important role of apoptosis in the pathogenesis
of emphysema, we ﬁrst explored if Cat E may affect
apoptosis.4,6,48 Apoptosis, or programed cell death, is
mediated by caspases, a family of speciﬁc cysteine proteases.
Among the members in the caspase family identiﬁed, caspase
3 is a main player in the effector phase of apoptosis induced
by a variety of stimuli. Caspase 3 activation is regulated by at
least two pathways: the intrinsic pathway, which involves the
mitochondria (mitochondrial pathway), and the extrinsic
pathway, which is stimulated by cell surface death receptors
(death receptor pathway), such as tumor necrosis factor re-
ceptor 1 and Fas. The death receptor pathway of apoptosis
usually leads to caspase 8 and 9 activation with subsequent
activation of caspase 3. Both pathways are thought to be
interlinked and converge on the mitochondria, whose outer
membranes become increasingly permeable.49 This increase
in the permeability of the mitochondrial outer membrane
causes proteins to leak out from the intermembranous space,
activation of caspase-3 and DNases, and ﬁnally apoptosis.
Given that we found increased caspase 3 activity in theajp.amjpathol.org - The American Journal of Pathology
Figure 9 Summary of the effects of Cat E on emphysema. We postulate
that Cat E overexpression leads to pulmonary emphysema by increasing
mitochondrial ﬁssion via Parkin, UPS, and Drp1 induction, thereby dis-
rupting the balance between mitochondrial ﬁssion and fusion, leading to
increased caspase 3-mediated cell death and ultimately emphysema.
Cathepsin E Promotes Pulmonary Emphysemaabsence of increased caspase 8 and 9 activities in response to
Cat E, we focused on the mitochondrial pathway. We
conﬁrmed that caspase 3 activity was part of the pathogenesis
of Cat E-induced emphysema by inhibiting caspase 3 with
Z-VAD, which decreased apoptosis and ameliorated
emphysema in Cat E Tg mouse lungs. Next, we examined
additional mitochondrial pathways that may be involved in
Cat E-induced emphysema.
Mitochondria, which have long been regarded only as
energy producers, are increasingly identiﬁed at the cross-
roads of many cellular functions.50 Mitochondria are highly
dynamic, complex organelles that continuously change their
shape through two opposite processes, ﬁssion and fusion.
Alterations in mitochondrial dynamics due to mutations in
proteins involved in the fusion/ﬁssion machinery represent
an important pathogenic mechanism of human diseases.51
The most common proteins involved in the mitochondrial
fusion process are three GTPase dynamin-like proteins:
Mfn1 and Mfn2, located in the outer mitochondrial mem-
brane, and Opa1, in the inner membrane. The most common
proteins involved in the mitochondrial ﬁssion process are
Drp1 and Fis1. Drp1 is a cytosolic dynamin-related GTPase
which plays a central role in ﬁssion by promoting mito-
chondrial division through its mitochondrial outer mem-
brane relocation and oligomerization/colocalization with
other molecules, including Fis1 and Bax. We found that CatThe American Journal of Pathology - ajp.amjpathol.orgE induces both Drp1 and Bax. Studies have found that Drp1
colocalizes with proapoptotic Bax at mitochondrial scission
sites, resulting in mitochondrial fragmentation (ﬁssion) and
cell apoptosis, and that these two processes occur almost
simultaneously.33,52 Inhibition of mitochondrial ﬁssion by
Drp1 knock-down delays cytochrome c release, indicating
that mitochondrial ﬁssion participates in Bax-mediated
permeabilization of the outer mitochondrial membrane,
caspase activation, and ultimately apoptosis.31,53 In our
models, Cat E appears to induce Drp1 and Bax, which shifts
the mitochondrial balance to favor ﬁssion, thereby leading
to increased mitochondrial fragmentation, cell apoptosis,
and loss of lung tissue. Our observation that inhibition of
Drp1 with Mdivi-1 in vivo completely prevented Cat
E-induced apoptosis and emphysema conﬁrms the pivotal
role mitochondrial dynamics has in emphysema.
The UPS plays essential roles in regulating mitochondria
dynamics.54 Mfn1/2, Fis1, and Drp1, major regulators of
mitochondrial fusion and ﬁssion, are degraded by the protea-
some.MITOL, a mitochondrial E3 ubiquitin ligase, is required
for Drp1-dependentmitochondrial ﬁssion because depletion or
inactivation of MITOL blocks mitochondrial fragmentation.55
Parkin, an E3 ubiquitin ligase, plays a critical role in regulating
mitochondrial ﬁssion and fusion.35 Interesting evidence links
the UPS to the initiation of Parkin-dependent mitochondrial
homeostasis.37 Studies reported the involvement of Parkin in
modulation of mitochondrial fusion/ﬁssion dynamics because
overexpression of Parkin facilitates mitochondrial ﬁssion in
mammalian primary neurons.56 Parkin, therefore, might
facilitate mitophagy by altering mitochondrial dynamics.
Consistent with this notion, Parkin-mediated proteasomal
degradation of mitofusins is a prerequisite for the initiation of
mitophagy. Stabilization of Mfn1/2 by inhibition of the pro-
teasome abolished the protonophores carbonyl cyanide
3-chlorophenylhydrazone-driven mitophagy.36 Recently,
Parkin-mediated mitochondrial clearance contributed to pro-
teasome activation during denervation atrophy in slow-twitch
muscles.57 Furthermore, Parkin has also been found to regulate
proapoptotic Bax by direct ubiquitination.58 Taken together,
the UPS appears to be closely linked to mitochondrial dy-
namics and is required for the tight regulation of Parkin-
dependent mitochondrial ﬁssion/fusion. In our present study,
we identiﬁed that Cat E treatment signiﬁcantly increased
Parkin expression and UPS activity, as measured by protea-
some 20 activity. Moreover, Drp1 expression was also regu-
lated by Cat E and Parkin, as found in siRNA studies. Taken
together, we identiﬁed a novel cathepsin as an upstream
inducer of Parkin, UPS activity, and Drp1-mediated apoptosis
and found a link between mitochondrial ﬁssion and caspase 3-
mediated apoptosis in vivo and in vitro.
It is well known that smoking is the most common identi-
ﬁable risk factor for developing COPD. Here, we identiﬁed
increased Cat E expression in human COPD lungs and
smokingmouse lungs. Inﬂammation plays an important role in
the pathogenesis of smoking-related COPD in both human and
mouse lungs. However, emphysema can occur in conditions2739
Zhang et alwith no signiﬁcant inﬂammation in the lungs, as found in Toll-
like receptor 4edeﬁcient mouse lungs,6 a1-antitrypsine
deﬁcient pallid mouse lungs,59 endothelin-2edeﬁcient mouse
lungs,60 or klotho gene-mutated mouse lungs.61 Similarly, Cat
E-induced emphysema is not associated with overt inﬂam-
mation. However, Cat E expression is increased by inﬂam-
matory stimuli, such as smoking, and may participate in the
progression of COPD. Additional studies will be needed to
elucidate the importance of Cat E in the pathogenesis of
smoking-related COPD. Recent reports described cigarette
smoke to induce mitochondrial fragmentation in airway
epithelial cells and even in airway smoothmuscle cells through
Drp1, Opa1, or Mfn2.62e64 However, proof of concept that
Drp1 induction mediates emphysema in vivo has not been
reported until our present studies, to the best of our knowledge.
Furthermore, we identiﬁed Cat E to be an upstream mecha-
nism of Drp1-induced emphysema and linked Cat E to Parkin
and UPS activity.
Conclusions
We used in vivo and in vitro approaches to show that Cat E
is a novel mediator of pulmonary emphysema. We
conﬁrmed Cat E expression is increased in both human
COPD lung and smoking mouse lung tissues. We also
identiﬁed previously unrecognized aspects of cathepsin
biology, namely the regulation of mitochondrial ﬁssion via
Parkin, UPS activation, Drp1, and downstream caspase 3
activation (Figure 9). These studies expand our under-
standing of the molecular mechanisms of emphysema and
may provide potential therapeutic target for the prevention
and treatment of emphysema.
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